This study examined apolipoprotein (apo) B metabolism in normolipemic subjects homozygous for the apo E2 (n = 4), apo E3 (n = 5), or apo E4 (n = 5) phenotype. Radioiodinated very low density lipoprotein (VLDL1) (ultracentrifuge flotation rate [Sf] 60-400) and VLDL2 (Sf 20-60) were injected into volunteers and the conversion of apo B was followed through intermediate density lipoprotein (IDL) to low density lipoprotein (LDL). Subjects homozygous for E3 converted approximately 50% of LVDL2 to LDL, the remainder being lost by direct catabolism. Those with the E2 phenotype produced less VLDL1, but converted more of it to VLDL2 (compared to E3 subjects). They displayed a characteristic dyslipidemia with the presence of slowly catabolized VLDL1 and VLDL2 remnants. LDL levels were low owing to increased direct catabolism of VLDL2 and IDL and a reduced efficiency of delipidation; only 25% of VLDL2 apo B was directed to LDL production. In contrast, E4 subjects converted more VLDL2 apo B to LDL than E3 subjects. About 70% of VLDL2 apo B was found in LDL; direct catabolism of VLDL and IDL was reduced as was the fractional catabolic rate of LDL (0.2 vs. 0.26 in E3 subjects). These changes in the VLDL----IDL----LDL metabolic cascade can in part be explained by alterations in hepatic LDL receptors with E2 subjects having higher and E4 subjects lower activities than those in E3 homozygotes.
T Demant, D Bedford, C J Packard, J Shepherd
Title and authors | Publication | Year |
---|---|---|
Large-scale genome-wide interaction analyses on multiple cardiometabolic risk factors to identify age-specific genetic risk factors.
Ao L, van Heemst D, Luo J, Teder-Laving M, Mägi R, Frikke-Schmidt R, Willems van Dijk K, Noordam R |
GeroScience | 2024 |
Causes and Consequences of Hypertriglyceridemia
CJ Packard, J Boren, MR Taskinen |
Frontiers in Endocrinology | 2020 |
Plasma ApoE elevations are associated with NAFLD: The PREVEND Study
EH van den Berg, JP Corsetti, SJ Bakker, RP Dullaart, P Bjornstad |
PloS one | 2019 |
APOE4 Genotype Exerts Greater Benefit in Lowering Plasma Cholesterol and Apolipoprotein B than Wild Type (E3/E3), after Replacement of Dietary Saturated Fats with Low Glycaemic Index Carbohydrates
B Griffin, C Walker, S Jebb, C Moore, G Frost, L Goff, T Sanders, F Lewis, M Griffin, R Gitau, J Lovegrove |
Nutrients | 2018 |
Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review
J Oscarsson, E Hurt-Camejo |
Lipids in Health and Disease | 2017 |
Effects of Apolipoprotein E Isoforms in Diabetic Nephropathy of Chinese Type 2 Diabetic Patients
YW Jiang, L Ma, CW Han, Q Liu, X Cong, YP Xu, TT Zhao, P Li, YT Cao |
Journal of Diabetes Research | 2017 |
Plasma apolipoproteins and physical and cognitive health in very old individuals
J Muenchhoff, F Song, A Poljak, JD Crawford, KA Mather, NA Kochan, Z Yang, JN Trollor, S Reppermund, K Maston, A Theobald, S Kirchner-Adelhardt, JB Kwok, RL Richmond, M McEvoy, J Attia, PW Schofield, H Brodaty, PS Sachdev |
Neurobiology of Aging | 2017 |
Relationship between Adipokines and Lipid Profile in Postmenopausal Women with Different Apoe Genotypes
M Gibas-Dorna, J Piątek, J Kupsz, M Bernatek, H Krauss, A Sowinska, P Kołodziejski, A Owoc, I Bojar |
Women & Health | 2016 |
Omega-3 Fatty Acids
RA Brown |
Omega-3 Fatty Acids | 2016 |
Hyperlipoproteinemia Type 3: The Forgotten Phenotype
PN Hopkins, EA Brinton, MN Nanjee |
Current Atherosclerosis Reports | 2014 |
Apoliprotein E genotype is associated with apoliprotein B plasma levels but not with coronary calcium score in very elderly individuals in primary care setting
AD Henriques, AC Tonet-Furioso, W Machado-Silva, WM Freitas, LA Quaglia, SN Santos, C Córdova, AC Sposito, OT Nóbrega |
Gene | 2014 |
Apolipoprotein E4 Domain Interaction Accelerates Diet-Induced Atherosclerosis in Hypomorphic Arg-61 Apoe Mice
D Eberlé, RY Kim, FS Luk, NS de Mochel, N Gaudreault, VR Olivas, N Kumar, JM Posada, AC Birkeland, JH Rapp, RL Raffai |
Arteriosclerosis, thrombosis, and vascular biology | 2012 |
Diagnostic markers based on a computational model of lipoprotein metabolism
DB van Schalkwijk, B Ommen, AP Freidig, J der Greef, AA de Graaf |
Journal of Clinical Bioinformatics | 2011 |
Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk
S Calandra, P Tarugi, HE Speedy, AF Dean, S Bertolini, CC Shoulders |
Journal of lipid research | 2011 |
Interactive effects of APOE haplotype, sex, and exercise on postheparin plasma lipase activities
RL Seip, RF Zoeller, TJ Angelopoulos, J Salonia, C Bilbie, NM Moyna, MP Miles, PS Visich, LS Pescatello, PM Gordon, GJ Tsongalis, L Bausserman, PD Thompson |
Journal of applied physiology | 2011 |
Integrated Role of Two Apoliprotein E Polymorphisms on Apolipoprotein B Levels and Coronary Artery Disease in a Biethnic Population
Z Ozturk, B Enkhmaa, NS Shachter, L Berglund, E Anuurad |
Metabolic Syndrome and Related Disorders | 2010 |
Contribution of apolipoprotein E genotype and docosahexaenoic acid to the LDL-cholesterol response to fish oil
E Olano-Martin, E Anil, MJ Caslake, CJ Packard, D Bedford, G Stewart, D Peiris, CM Williams, AM Minihane |
Atherosclerosis | 2010 |
Novartis Foundation Symposia
EJ Campbell |
Ciba Foundation Symposium 44 - Research and Medical Practice: Their Interaction | 2008 |
Association of Apolipoprotein E Polymorphisms in Patients with Non-Alcoholic Steatohepatitis
A Sazci, G Akpinar, C Aygun, E Ergul, O Senturk, S Hulagu |
Digestive Diseases and Sciences | 2008 |
Personalized nutrition for the prevention of cardiovascular disease: a future perspective
JA Lovegrove, R Gitau |
Journal of Human Nutrition and Dietetics | 2008 |
Apolipoprotein E Gene Polymorphism in Nonalcoholic Fatty Liver Disease
MD Demirag, HI Onen, MY Karaoguz, I Dogan, T Karakan, A Ekmekci, G Guz |
Digestive Diseases and Sciences | 2007 |
ApoE genotype, cardiovascular risk and responsiveness to dietary fat manipulation
AM Minihane, L Jofre-Monseny, E Olano-Martin, G Rimbach |
Proceedings of the Nutrition Society | 2007 |
Apolipoprotein E genotype affects the response to lipid-lowering therapy in Chinese patients with type 2 diabetes mellitus
S Tavintharan, SC Lim, YH Chan, CF Sum |
Diabetes, Obesity and Metabolism | 2007 |
Structural variation manipulates the differential oxidative susceptibility and conformational stability of apolipoprotein E isoforms
KL Su, TH Wen, CY Chou, GG Chang, GY Liu, HC Hung |
Proteins: Structure, Function, and Bioinformatics | 2007 |
The effect of apolipoprotein E genotype on serum lipoprotein particle response to exercise
RL Seip, J Otvos, C Bilbie, GJ Tsongalis, M Miles, R Zoeller, P Visich, P Gordon, TJ Angelopoulos, L Pescatello, N Moyna, PD Thompson |
Atherosclerosis | 2006 |
Influencia de los factores genéticos y ambientales en el metabolismo lipídico y riesgo cardiovascular asociado al gen apoE
JA Moreno, J López-Miranda, F Pérez-Jiménez |
Medicina Clínica | 2006 |
Apolipoprotein E polymorphism in the Tunisian population: Frequency and effect on lipid parameters
R Jemaa, M Elasmi, C Naouali, M Feki, A Kallel, M Souissi, H Sanhaji, SH Taïeb, O Souheil, N Kaabachi |
Clinical Biochemistry | 2006 |
LDL composition in E2/2 subjects and LDL distribution by Apo E genotype in type 1 diabetes.
Murdoch SJ, Boright AP, Paterson AD, Zinman B, Steffes M, Cleary P, Edwards K, Marcovina SS, Purnell JQ, Brunzell JD |
Atherosclerosis | 2006 |
Characterisation of the lipoprotein structure in the St. Thomas’ Mixed Hyperlipidaemic (SMHL) rabbit
B Roos, MJ Caslake, K Milliner, GM Benson, KE Suckling, CJ Packard |
Atherosclerosis | 2005 |
The effect of apolipoprotein E polymorphism on lipid levels in Korean adults
MH Shin, HN Kim, LH Cui, SS Kweon, KS Park, H Heo, HS Nam, SK Jeong, EK Chung, JS Choi |
Journal of Korean Medical Science | 2005 |
Structural variation in human apolipoprotein E3 and E4: secondary structure, tertiary structure, and size distribution
CY Chou, YL Lin, YC Huang, SY Sheu, TH Lin, HJ Tsay, GG Chang, MS Shiao |
Biophysical Journal | 2005 |
Familial hypercholesterolemia in children
J Rodenburg, MN Vissers, A Wiegman, MD Trip, HD Bakker, JJ Kastelein |
Current Opinion in Lipidology | 2004 |
Metabolic abnormalities: triglyceride and low-density lipoprotein
RM Krauss, PW Siri |
Endocrinology & Metabolism Clinics of North America | 2004 |
Apolipoprotein E gene polymorphism in renal transplant recipients: effects on lipid metabolism, atherosclerosis and allograft function
S Kahraman, AA Kiykim, B Altun, G Genctoy, M Arici, M Gulsun, Y Erdem, U Yasavul, C Turgan, S Caglar |
Clinical Transplantation | 2004 |
Heritability of C-Reactive Protein and Association with Apolipoprotein E Genotypes in Japanese Americans
MA Austin, C Zhang, SE Humphries, WL Chandler, PJ Talmud, KL Edwards, DL Leonetti, MJ Mcneely, WY Fujimoto |
Annals of Human Genetics | 2004 |
Apolipoprotein E polymorphism in Vietnamese children and its relationship to plasma lipid and lipoprotein levels
NN Thu, TT Mai, R Ohmori, M Kuroki, NV Chuyen, NT Hung, M Kawakami, K Kondo |
Metabolism | 2004 |
Abnormal in vivo metabolism of apoB-containing lipoproteins in human apoE deficiency
K Ikewaki, W Cain, F Thomas, R Shamburek, LA Zech, D Usher, HB Brewer, DJ Rader |
Journal of lipid research | 2004 |
Hepatic Catabolism of Remnant Lipoproteins: Where the Action Is
RJ Havel, RL Hamilton |
Arteriosclerosis, thrombosis, and vascular biology | 2004 |
Influence of apolipoprotein E genotype on the response to caloric restriction in type 2 diabetic patients with hyperlipidaemia
N Tamasawa, H Murakami, K Yamato, J Matsui, J Tanabe, T Suda |
Diabetes, Obesity and Metabolism | 2003 |
A prospective study of the association between APOE genotype and the risk of myocardial infarction among apparently healthy men
S Liu, J Ma, PM Ridker, JL Breslow, MJ Stampfer |
Atherosclerosis | 2003 |
The Apolipoprotein ε4 Allele Confers Additional Risk in Children with Familial Hypercholesterolemia
A Wiegman, EJ Sijbrands, J Rodenburg, JC Defesche, S Jongh, HD Bakker, JJ Kastelein |
Pediatric Research | 2003 |
Association of apo E polymorphism with variations in lipid and small dense LDL in koreans with alow fat intake
MJ Shin, EY Cho, HY Park, HK Cho, JH Lee, Y Jang |
Nutrition Research | 2003 |
Gender-specific effects of apolipoprotein E genotype on plasma lipid levels in a population-based sample of 6-7-year-old children in Spain
C Garcés, M Benavente, MA Lasunción, H Ortega, G Nájera, M Oya |
Acta Paediatrica | 2002 |
Comparative in vivo metabolism of apolipoproteins E2 and E4 in heterozygous apoE2/4 subjects
K Ikewaki, LA Zech, HB Brewer, DJ Rader |
Journal of Laboratory and Clinical Medicine | 2002 |
Metabolic origins and clinical significance of LDL heterogeneity
KK Berneis, RM Krauss |
Journal of lipid research | 2002 |
Hepatic steatosis and very low density lipoprotein secretion: the involvement of apolipoprotein E
AR Mensenkamp, LM Havekes, JA Romijn, F Kuipers |
Journal of Hepatology | 2001 |
Differential metabolism of human VLDL according to content of ApoE and ApoC-III
K Tomiyasu, BW Walsh, K Ikewaki, H Judge, FM Sacks |
Arteriosclerosis, thrombosis, and vascular biology | 2001 |
The coffee diterpene cafestol increases plasma triacylglycerol by increasing the production rate of large VLDL apolipoprotein B in healthy normolipidemic subjects
B de Roos, MJ Caslake, AF Stalenhoef, D Bedford, PN Demacker, MB Katan, CJ Packard |
The American journal of clinical nutrition | 2001 |
Mice Expressing Only the Mutant APOE3Leiden Gene Show Impaired VLDL Secretion
AR Mensenkamp, B Teusink, JF Baller, H Wolters, R Havinga, KW van Dijk, LM Havekes, F Kuipers |
Arteriosclerosis, thrombosis, and vascular biology | 2001 |
Association of apolipoprotein (Apo)E genotype with plasma apo E levels
IA Larson, JM Ordovas, C DeLuca, JR Barnard, G Feussner, EJ Schaefer |
Atherosclerosis | 2000 |
GENETICS OFLIPOPROTEINABNORMALITIESASSOCIATED WITHCORONARYHEARTDISEASESUSCEPTIBILITY
JL Breslow |
Annual Review of Genetics | 2000 |
Gene-diet interactions and plasma lipoproteins: Role of apolipoprotein E and habitual saturated fat intake
H Campos, M D?Agostino, JM Ordov�s |
Genetic Epidemiology | 2000 |
Effects of ApoE genotype on ApoB-48 and ApoB-100 kinetics with stable isotopes in humans
FK Welty, AH Lichtenstein, PH Barrett, JL Jenner, GG Dolnikowski, EJ Schaefer |
Arteriosclerosis, thrombosis, and vascular biology | 2000 |
Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E
AD Dergunov, EA Smirnova, A Merched, S Visvikis, G Siest, VV Yakushkin, V Tsibulsky |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2000 |
Lipoprotein Metabolism and Atherogenesis
T Kita, M Yokode |
2000 | |
Genotypic associations of the hepatic secretion of VLDL apolipoprotein B-100 in obesity
GF Watts, FM Riches, SE Humphries, PJ Talmud, FM van Bockxmeer |
Journal of lipid research | 2000 |
Apo E structure determines VLDL clearance and atherosclerosis risk in mice
C Knouff, ME Hinsdale, H Mezdour, MK Altenburg, M Watanabe, SH Quarfordt, PM Sullivan, N Maeda |
Journal of Clinical Investigation | 1999 |
Apolipoprotein E and atherosclerosis: insight from animal and human studies
J Davignon, JS Cohn, L Mabile, L Bernier |
Clinica Chimica Acta | 1999 |
Variation of apolipoprotein B as a possible cause of decreased low density lipoprotein clearance and hypercholesterolemia
T Korhonen, MJ Savolainen, YA Kesäniemi |
Atherosclerosis | 1999 |
Apolipoprotein E polymorphism in men and women from a Spanish population: allele frequencies and influence on plasma lipids and apolipoproteins
D Gómez-Coronado, JJ Álvarez, A Entrala, JM Olmos, E Herrera, MÁ Lasunción |
Atherosclerosis | 1999 |
Effect of heparin-stimulated plasma lipolytic activity on VLDL APO B subclass metabolism in normal subjects
R Malmström, CJ Packard, M Caslake, D Bedford, P Stewart, J Shepherd, MR Taskinen |
Atherosclerosis | 1999 |
Apolipoprotein E phenotypes in hemodialysis patients
T Imura, H Kimura, F Gejyo |
Kidney International | 1999 |
Relationship between the apolipoprotein E and angiotensin-converting enzyme genotypes and LDL particle size in Japanese subjects
K Okumura, H Matsui, K Kawakami, Y Numaguchi, S Kaneko, I Morishima, S Mokuno, Y Toki, T Hayakawa |
Clinica Chimica Acta | 1999 |
Human apolipoprotein (Apo) B-48 and ApoB-100 kinetics with stable isotopes
FK Welty, AH Lichtenstein, PH Barrett, GG Dolnikowski, EJ Schaefer |
Arteriosclerosis, thrombosis, and vascular biology | 1999 |
Postprandial lipoprotein metabolism and atherosclerosis
F Karpe |
Journal of Internal Medicine | 1999 |
Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes
CD Mamotte, M Sturm, JI Foo, FM van Bockxmeer, RR Taylor |
American journal of physiology. Endocrinology and metabolism | 1999 |
Independent Effects of Apo E Phenotype and Plasma Triglyceride on Lipoprotein Particle Sizes in the Fasting and Postprandial States
AM Dart, B Cooper |
Arteriosclerosis, thrombosis, and vascular biology | 1999 |
Apolipoprotein E polymorphism and the distribution profile of very low density lipoproteins; an influence of the E4 allele on large (Sf>60) particles
S Bioletto, P Fontana, R Darioli, RW James |
Atherosclerosis | 1998 |
Apolipoprotein E phenotype associations with plasma lipoproteins and bone mass in postmenopausal women
M Sanada, H Nakagawa, I Kodama, T Sakasita, K Ohama |
Climacteric | 1998 |
Lack of interaction of apolipoprotein E phenotype with the lipoprotein response to lovastatin or gemfibrozil in patients with primary hypercholesterolemia
C Sanllehy, E Casals, C Rodriguez-Villar, D Zambón, J Ojuel, AM Ballesta, E Ros |
Metabolism | 1998 |
Apolipoprotein B metabolism in hypertriglyceridemic diabetic patients administered either a fish oil- or vegetable oil-enriched diet
WR Fisher, LA Zech, PW Stacpoole |
Journal of lipid research | 1998 |
Apolipoprotein B signal peptide and apolipoprotein E genotypes as determinants of the hepatic secretion of VLDL apoB in obese men
FM Riches, GF Watts, FM van Bockxmeer, J Hua, S Song, SE Humphries, PJ Talmud |
Journal of lipid research | 1998 |
A dietary and behavioral intervention designed to lower coronary heart disease. Risk factors are unaffected by variation at the APOE gene locus
A Pasagian-Macaulay |
Atherosclerosis | 1997 |
Direct association between the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 and plasma mevalonic acid and lathosterol concentrations in man
FM Riches, GF Watts, RP Naoumova, JM Kelly, KD Croft, GR Thompson |
Atherosclerosis | 1997 |
DETERMINANTS OF THE KINETICS OF VERY LOW-DENSITY LIPOPROTEIN APOLIPOPROTEIN B-100 IN NON-OBESE MEN
GF Watts, FM Riches, JM Kelly, MA Powell, KD Croft |
Clinical and Experimental Pharmacology and Physiology | 1997 |
Genetic predictors of common disease: Apolipoprotein E genotype as a paradigm
GP Jarvik |
Annals of Epidemiology | 1997 |
Evidence That the Apolipoprotein E-Genotype Effects on Lipid Levels Can Change with Age in Males: A Longitudinal Analysis
GP Jarvik, EL Goode, MA Austin, J Auwerx, S Deeb, GD Schellenberg, T Reed |
The American Journal of Human Genetics | 1997 |
Heritability of Longitudinal Changes in Coronary-Heart-Disease Risk Factors in Women Twins
Y Friedlander, MA Austin, B Newman, K Edwards, EJ Mayer-Davis, MC King |
The American Journal of Human Genetics | 1997 |
Effect of Apolipoprotein E Phenotype on Plasma Lipids and Lipoproteins in Alcohol Abusers
MJ Liinamaa, K Kervinen, ML Hannuksela, YA Kesaniemi, MJ Savolainen |
Alcoholism, clinical and experimental research | 1997 |
Heritability of longitudinal changes in coronary-heart-disease risk factors in women twins
Y Friedlander, MA Austin, B Newman, K Edwards, EI Mayer-Davis, MC King |
The American Journal of Human Genetics | 1997 |
Very-low-density lipoprotein subfraction composition and metabolism by adipose tissue
RM Fisher, JM Miles, BA Kottke, KN Frayn, SW Coppack |
Metabolism | 1997 |
Lipoprotein Heterogeneity and Apolipoprotein B Metabolism
CJ Packard, J Shepherd |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
Association of Apo E Polymorphism With Plasma Lipid Levels in a Multiethnic Elderly Population
A Pablos-Méndez, R Mayeux, C Ngai, S Shea, L Berglund |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
Lipoprotein Kinetics in Patients With Analbuminemia: Evidence for the Role of Serum Albumin in Controlling Lipoprotein Metabolism
C Maugeais, S Braschi, K Ouguerram, P Maugeais, P Mahot, B Jacotot, D Darmaun, T Magot, M Krempf |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
Effect of apolipoprotein E and insulin resistance on VLDL particles in combined hyperlipidemic patients
EJ Sijbrands, RG Westendorp, MJ Hoffer, RR Frants, AE Meinders, JH Souverijn, JA Leuven, AV der Laarse, LM Havekes, AH Smelt |
Atherosclerosis | 1996 |
Effects of apo B and apo E gene polymorphisms on lipid and apolipoprotein concentrations after a test meal
A Regis-Bailly, S Visvikis, J Steinmetz, B Fournier, R Gueguen, G Siest |
Clinica Chimica Acta | 1996 |
Review
M Epstein |
Renal Failure | 1996 |
Triglycerides: a risk factor for coronary heart disease
J Davignon, JS Cohn |
Atherosclerosis | 1996 |
Influence of apolipoprotein E genotypes on plasma lipid and lipoprotein concentrations: Results from a segregation analysis in pedigrees with molecularly defined familial hypercholesterolemia
Y Friedlander, E Leitersdorf |
Genetic Epidemiology | 1996 |
The effect of physical activity on serum total and low-density lipoprotein cholesterol concentrations varies with apolipoprotein E phenotype in male children and young adults: The cardiovascular risk in young finns study
S Taimela, T Lehtimäki, KV Porkka, L Räsänen, JS Viikari |
Metabolism | 1996 |
Clinical chemistry of common apolipoprotein E isoforms
DA Brouwer, JJ van Doormaal, FA Muskiet |
Journal of Chromatography B: Biomedical Sciences and Applications | 1996 |
In the Absence of Endogenous Mouse Apolipoprotein E, Apolipoprotein E*2(Arg-158 → Cys) Transgenic Mice Develop More Severe Hyperlipoproteinemia than Apolipoprotein E*3-Leiden Transgenic Mice
BJ van Vlijmen, KW van Dijk, HB Hof, PJ van Gorp, A der Zee, H der Boom, ML Breuer, MH Hofker, LM Havekes |
The Journal of biological chemistry | 1996 |
The Underlying Molecular Mechanism of Apolipoprotein E Polymorphism: Relationships to Lipid Disorders, Cardiovascular Disease, and Alzheimer’s Disease
JH Contois, DE Anamani, GJ Tsongalis |
Clinics in Laboratory Medicine | 1996 |
Apolipoprotein E Polymorphism and LDL Size in a Biethnic Population
SM Haffner, MP Stern, H Miettinen, D Robbins, BV Howard |
Arteriosclerosis, thrombosis, and vascular biology | 1996 |
Effects of Colestipol Alone and in Combination With Simvastatin on Apolipoprotein B Metabolism
A Gaw, CJ Packard, GM Lindsay, EF Murray, BA Griffin, MJ Caslake, I Colquhoun, DJ Wheatley, AR Lorimer, J Shepherd |
Arteriosclerosis, thrombosis, and vascular biology | 1996 |
Drugs Affecting Lipid Metabolism
AM Gotto, R Paoletti, LC Smith, AL Catapano, AS Jackson |
1996 | |
Triggering of Acute Coronary Syndromes
SN Willich, JE Muller |
1996 | |
Apolipoprotein (apo) E genotype and apoE concentration determine binding of normal very low density lipoproteins to HepG2 cell surface receptors
K Bohnet, T Pillot, S Visvikis, N Sabolovic, G Siest |
Journal of lipid research | 1996 |
Effects of the apolipoprotein E polymorphism on uptake and transfer of cell-derived cholesterol in plasma
Y Huang, A Eckardstein, S Wu, G Assmann |
Journal of Clinical Investigation | 1995 |
Apolipoprotein E Isoform Phenotype and LDL Subclass Response to a Reduced-Fat Diet
DM Dreon, HA Fernstrom, B Miller, RM Krauss |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
Multiple Risk Factors in Cardiovascular Disease
AM Gotto, C Lenfant, AL Catapano, R Paoletti |
1995 | |
Cardiovascular Disease 2
LL Gallo |
1995 | |
Development and application of a multicompartmental model to study very low density lipoprotein subfraction metabolism
CJ Packard, A Gaw, T Demant, J Shepherd |
Journal of lipid research | 1995 |
Molecular characterization of two monoclonal antibodies specific for the LDL receptor-binding site of human apolipoprotein E
R Raffai, R Maurice, K Weisgraber, T Innerarity, X Wang, R MacKenzie, T Hirama, D Watson, E Rassart, R Milne |
Journal of lipid research | 1995 |
Overproduction of small very low density lipoproteins (Sf 20-60) in moderate hypercholesterolemia: relationships between apolipoprotein B kinetics and plasma lipoproteins
A Gaw, CJ Packard, GM Lindsay, BA Griffin, MJ Caslake, AR Lorimer, J Shepherd |
Journal of lipid research | 1995 |
Association between serum lipids and apolipoprotein E phenotype is influenced by diet in a population-based sample of free-living children and young adults: the Cardiovascular Risk in Young Finns Study
T Lehtimäki, T Moilanen, K Porkka, HK Akerblom, T Rönnemaa, L Räsänen, J Viikari, C Ehnholm, T Nikkari |
Journal of lipid research | 1995 |
Triglyceride-rich lipoproteins of subjects heterozygous for apolipoprotein E2(Lysl46→Gln) are inefficiently converted to cholesterol-rich lipoproteins
M Mulder, H der Boom, P Kniff, C Braam, A Maagdenberg, JA Leuven, LM Havekes |
Atherosclerosis | 1994 |
Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels
P Knijff, AM van Maagdenberg, RR Frants, LM Havekes |
Human Mutation | 1994 |
Genetic influences on age-related change in total cholesterol, low density lipoprotein-cholesterol and triglyceride levels: Longitudinal apolipoprotein E genotype effects
GP Jarvik, MA Austin, RR Fabsitz, J Auwerx, T Reed, JC Christian, S Deeb |
Genetic Epidemiology | 1994 |
Effects of ciprofibrate on LDL metabolism in man
A Gaw, CJ Packard, MJ Caslake, BA Griffin, GM Lindsay, J Thomson, BD Vallance, D Wosornu, J Shepherd |
Atherosclerosis | 1994 |
Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from the Framingham Offspring Study
EJ Schaefer, S Lamon-Fava, S Johnson, JM Ordovas, MM Schaefer, WP Castelli, PW Wilson |
Arteriosclerosis Thrombosis and Vascular Biology | 1994 |
Genetic factors in coronary heart disease
U Goldbourt, U de Faire, K Berg |
1994 | |
Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol
J Lopez-Miranda, JM Ordovas, P Mata, AH Lichtenstein, B Clevidence, JT Judd, EJ Schaefer |
Journal of lipid research | 1994 |
Apolipoprotein E phenotype and lipoprotein(a) in familial hypercholesterolaemia implication for lipoprotein(a) metabolism
G Lindahl, F Mailly, S Humphries, M Seed |
The Clinical Investigator | 1994 |
Apolipoprotein E phenotypes in familial hypercholesterolaemia: importance for expression of disease and response to therapy
L Berglund, O Wiklund, G Eggertsen, SO Olofsson, M Eriksson, T Lindén, G Bondjers, B Angelin |
Journal of Internal Medicine | 1993 |
Relationship between apolipoprotein E and low density lipoprotein particle size
SP Zhao, MH Verhoeven, J Vink, L Hollaar, A der Laarse, P Knijff, FM Hooft |
Atherosclerosis | 1993 |
Different hydrolytic efficiencies of adipose tissue lipoprotein lipase on very-low-density lipoprotein subfractions separated by heparin-Sepharose chromatography
D Gómez-Coronado, GT Sáez, MA Lasunción, E Herrera |
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism | 1993 |
Fenofibrate and LDL metabolic heterogeneity in hypercholesterolemia
MJ Caslake, CJ Packard, A Gaw, E Murray, BA Griffin, BD Vallance, J Shepherd |
Arteriosclerosis Thrombosis and Vascular Biology | 1993 |
Effects of simvastatin on apoB metabolism and LDL subfraction distribution
A Gaw, CJ Packard, EF Murray, GM Lindsay, BA Griffin, MJ Caslake, BD Vallance, AR Lorimer, J Shepherd |
Arteriosclerosis Thrombosis and Vascular Biology | 1993 |
Low density lipoprotein receptors bind and mediate cellular catabolism of normal very low density lipoproteins in vitro
DA Chappell, GL Fry, MA Waknitz, LE Muhonen, MW Pladet |
The Journal of biological chemistry | 1993 |
Metabolism of apoB-100-containing lipoproteins in familial hyperchylomicronemia
T Demant, A Gaw, GF Watts, P Durrington, B Buckley, CW Imrie, C Wilson, CJ Packard, J Shepherd |
Journal of lipid research | 1993 |
Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: relationship to apolipoprotein E genotype
LJ Martin, PW Connelly, D Nancoo, N Wood, ZJ Zhang, G Maguire, E Quinet, AR Tall, YL Marcel, R McPherson |
Journal of lipid research | 1993 |
Inefficient degradation of triglyceride-rich lipoprotein by HepG2 cells is due to a retarded transport to the lysosomal compartment
P Lombardi, M Mulder, H van der Boom, RR Frants, LM Havekes |
The Journal of biological chemistry | 1993 |
Effect of pravastatin on metabolic parameters of apolipoprotein B in patients with mixed hyperlipoproteinemia
KG Parhofer, PH Barrett, J Dunn, G Schonfeld |
The Clinical Investigator | 1993 |
The effect of the apolipoprotein E phenotype on plasma lipids is not influenced by environmental variability: results of a Dutch twin study
P de Knijff, DI Boomsma, E de Wit, HJ Kempen, JA Leuven, RR Frants, LM Havekes |
Human Genetics | 1993 |
Cholesterol absorption, elimination, and synthesis related to LDL kinetics during varying fat intake in men with different apoprotein E phenotypes
TA Miettinen, H Gylling, H Vanhanen, A Ollus |
Arteriosclerosis Thrombosis and Vascular Biology | 1992 |